Solid Biosciences (SLDB) Cash & Equivalents Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 214.58% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.50% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -4.13% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 3.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 67.78% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 41.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.05% |
| Dec 31, 2025 | -25.34% |
| Sep 30, 2025 | -4.71% |
| Jun 30, 2025 | 44.94% |
| Mar 31, 2025 | 79.15% |
| Dec 31, 2024 | 8.40% |
| Sep 30, 2024 | 31.32% |
| Jun 30, 2024 | 4.68% |
| Mar 31, 2024 | -28.59% |
| Dec 31, 2023 | -52.37% |
| Sep 30, 2023 | 0.51% |
| Jun 30, 2023 | 68.60% |
| Mar 31, 2023 | 26.94% |
| Dec 31, 2022 | 30.43% |
| Sep 30, 2022 | -55.51% |
| Jun 30, 2022 | -72.93% |
| Mar 31, 2022 | -51.69% |
| Dec 31, 2021 | -23.17% |
| Sep 30, 2021 | 342.30% |
| Jun 30, 2021 | 392.07% |
| Mar 31, 2021 | 401.73% |
| Dec 31, 2020 | 103.93% |
| Sep 30, 2020 | -73.91% |
| Jun 30, 2020 | -21.84% |
| Mar 31, 2020 | -1.49% |
| Dec 31, 2019 | -11.95% |
| Sep 30, 2019 | -26.53% |
| Jun 30, 2019 | -64.29% |
| Mar 31, 2019 | -67.09% |
| Dec 31, 2018 | 65.63% |
| Sep 30, 2018 | 761.52% |
| Jun 30, 2018 | 346.45% |
| Mar 31, 2018 | 464.05% |